![Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques](https://www.future-science.com/cms/10.2144/btn-2019-0071/asset/images/medium/figure2.gif)
Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing | BioTechniques
![Extraction and Quality Analysis of Circulating, Cell-Free DNA from Serum Samples Using Omega Bio-tek Kits | Omega Bio-tek Extraction and Quality Analysis of Circulating, Cell-Free DNA from Serum Samples Using Omega Bio-tek Kits | Omega Bio-tek](https://t7f7p5m3.rocketcdn.me/wp-content/uploads/2017/11/cfdna-fig1.png)
Extraction and Quality Analysis of Circulating, Cell-Free DNA from Serum Samples Using Omega Bio-tek Kits | Omega Bio-tek
![Verinata Health, Inc. v. Ariosa Diagnostics, Inc. United States Court of Appeals of the Federal Circuit, 2020 No. 2018-2198, 2020 WL 1970571 (Nonprecedential): Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*: Verinata Health, Inc. v. Ariosa Diagnostics, Inc. United States Court of Appeals of the Federal Circuit, 2020 No. 2018-2198, 2020 WL 1970571 (Nonprecedential): Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*:](https://www.liebertpub.com/cms/10.1089/blr.2020.29185.cmh/asset/images/medium/blr.2020.29185.cmh_figure1.jpg)